Specialties

Pioglitazone (Actos) appeared, at worst, neutral for cardiovascular risk, except heart failure, in yet another meta-analysis examining thiazolidinedione safety.

Although estimates have been adjusted downward in light of the most recent data, researchers still predict sharp increases in the U.S. incidence and prevalence of end-stage renal disease (ESRD) in the years ahead, according to a paper presented at the American Society of Nephrology’s 40th Annual Meeting and Scientific Exposition..

New research results suggest that a hormone therapy, commonly used to treat prostate cancer, called androgen-deprivation therapy may increase the risk of diabetes, particularly in obese men and patients should be made aware of this.

This may be the first product to directly treat gastroparesis by restoring gastrointestinal nitric oxide synthase, thereby increasing stomach motility and improving blood glucose control.

Creatinine screening needed in addition to albuminuria testing.

The FDA warned healthcare professionals that sudden loss of hearing has been reported in patients taking phosphodiesterase 5 (PDE-5) inhibitors.

Insulin, it turns out, may be as important for the mind as it is for the body. Research in the last few years has raised the possibility that Alzheimer’s memory loss could be due to a novel third form of diabetes.

Angiotensin-converting enzyme inhibitors that cross the blood-brain barrier slow mental decline by about 50% relative to the decline seen in patients on other antihypertensives, according to an observational study of 1,074 hypertensive subjects followed for a median of 6 years.

Researchers at Columbia University in New York have discovered that certain bone cells produce a hormone called osteocalcin, which influences beta-cell proliferation and controls the metabolism of blood sugar (glucose) and fat deposits through previously unknown mechanisms.

A type 2 diabetes drug taken orally and in widespread use for more than a decade has been found to have distinct advantages over nine other, mostly newer medications used to control the chronic disease, according to a study by researchers at Johns Hopkins.